...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Separation of active and inactive forms of human antithrombin by heparin affinity chromatography.
【24h】

Separation of active and inactive forms of human antithrombin by heparin affinity chromatography.

机译:通过肝素亲和色谱法分离活性和非活性形式的人类抗凝血酶。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

During the manufacturing of an antithrombin preparation, it is necessary to define all steps that may damage or alter the target molecule, and thus decrease the biological activity of the inhibitor in blood coagulation. Pasteurization, commonly used procedure for viral inactivation of plasma derived antithrombin concentrates, was shown to partially alter the conformation of the active native antithrombin to an inactive latent form. To study intensively the different forms of inactive antithrombin that are formed upon heat treatment, human alpha-antithrombin, human beta-antithrombin and an equimolar mixture of the two isoforms were incubated at 60 degrees C for 15 h in the presence of citrate as stabilizing agent. Using two subsequent heparin affinity chromatography steps, three different inactive fractions were separated. By comparison of the heparin binding capacities, isoelectric points and unfolding characteristics of these inactive forms, the alpha-latent and beta-latent antithrombin isoforms could be identified. It was also shown that additional inactive forms such as proteinase cleaved and/or oxidized forms of antithrombin are formed during the heat treatment process. In four commercially available antithrombin preparations, all produced by pasteurization, the amount of inactive protein varied between 0.5% and 9.5%.
机译:在抗凝血酶制剂的生产过程中,有必要定义所有可能破坏或改变靶分子,从而降低血液凝固中抑制剂的生物活性的步骤。巴斯德消毒法是血浆衍生的抗凝血酶浓缩物病毒灭活的常用方法,已显示出将活性天然抗凝血酶的构象部分改变为无活性的潜在形式。为了深入研究热处理后形成的不同形式的无活性抗凝血酶,将人α-抗凝血酶,人β-抗凝血酶和两种同工型的等摩尔混合物在柠檬酸盐作为稳定剂存在下于60摄氏度孵育15小时。 。使用随后的两个肝素亲和层析步骤,分离了三个不同的非活性级分。通过比较这些非活性形式的肝素结合能力,等电点和展开特征,可以鉴定出α潜伏性和β潜伏性抗凝血酶同工型。还显示在热处理过程中形成了另外的无活性形式,例如蛋白酶切割的抗凝血酶和/或氧化形式的抗凝血酶。在全部通过巴氏灭菌法生产的四种市售抗凝血酶制剂中,非活性蛋白的量在0.5%至9.5%之间变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号